BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

AIM Vaccine Advances High Efficiency Diploid Rabies Vaccine Into Final Clinical Stage

AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficie...

January 19, 2026 | News

Hyundai BioScience Sets Out A Pre Emptive Antiviral Play To Tackle Multiple Viruses With One Drug

- UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks...

January 19, 2026 | News

Docquity Launches Engage To Bring Ai Powered Market Intelligence To HCP Engagement Across Asia

Docquity, a leading health tech company in Asia, announced the launch of Docquity EngageTM, an AI&nb...

January 16, 2026 | News

Animate Biosciences Delivers Ai Designed Peptides That Match Standard Of Care In Pulmonary Fibrosis Model

Animate Biosciences announces positive preclinical results from a mouse model of pulmonary fibrosis demonstrating that two of its AI-designed therapeu...

January 15, 2026 | News

Novartis Secures Worldwide Licence To PepLib Peptide Asset To Expand Radioligand Therapy Pipeline

Zonsen PepLib Biotech Inc. announced that it has entered into a worldwide license agreement with Novartis for an undisclosed peptide-based asset in t...

January 15, 2026 | News

Australia TGA Clears NMN As A Permissible Therapeutic Ingredient In Landmark Longevity Move

One of the most popular ingredients in the field of longevity science globally, nicotinamide mononucleotide (NMN) has officially been listed as...

January 15, 2026 | News

Thermo Fisher And NVIDIA Join Forces To Build The AI Powered Laboratory Of The Future

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced a strategic collaboration with NVIDIA to power AI-based solutions...

January 13, 2026 | News

Clover Advances Global First In Class Respiratory Vaccine Strategy With Phase Two Launch

- Phase 2 Initiation Strengthens Global First-in-Class Potential for Clover's Protein-Based RSV + hMPV ± PIV3 Respiratory Combination Vaccine Candid...

January 13, 2026 | News

Kainova Therapeutics Rebrands To Power The Next Wave Of GPCR Driven Clinical Growth

Kainova Therapeutics rebrand reflects expanding capabilities powering next stage of corporate growth Kainova champions scientific agility, bold ambition...

January 13, 2026 | News

China Approves ArkBio Aizhida For ADHD With Rapid Onset And All Day Symptom Control

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the...

January 12, 2026 | News

Zai Lab Secures China Approval For AUGTYRO In NTRK Fusion Positive Solid Tumours

-Zai Lab Limited announced that China’s National Medical Products Administration (NMPA) has approved the supplemental New Drug Application (sND...

January 09, 2026 | News

UP Oncolytics Wins $75,000 Illinois Innovation Voucher To Advance Breakthrough Glioblastoma Therapy

UP Oncolytics, a biotech company in Rosalind Franklin University's Helix 51 biomedical incubator, was awarded an Illinois Innovation Voucher gran...

January 09, 2026 | News

ASGCT And Orphan Therapeutics Accelerator Launch CGTxchange To Revive Stalled Cell And Gene Therapies

First-of-its-kind venture to facilitate and catalyze development of deprioritized cell and gene therapies, supported by AI-enabled platform The American S...

January 09, 2026 | News

Title21 Acquires MyCellHub To Strengthen Digital Manufacturing And Quality Leadership

Strategic acquisition accelerates Title21’s mission to deliver comprehensive, compliant, and integrated digital solutions for regulated healthcare an...

January 08, 2026 | News

Stay Connected